CytomX Therapeutics Inc. (CTMX) Surged 6.92% or 1.78 To Price $27.51 On Monday


CytomX Therapeutics Inc. (CTMX) surged 6.92% or 1.78 to $27.51. It is close to 415580 shares traded, which is 113.56% compare to the average total volume 365941. The market cap of CTMX is $1.06 billion. The year to date change is 18.24%. The 52 week price range is from $11.11 to $27.51. Price of CTMX have changed -2.17% during last week. It have changed 16.80% over last month, 32.49% over last 3 months, 82.09% over last 6 months and 121.05% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTMX is 22.42. It is -18.50% below current price. The 200-day Moving Averages for CTMX is 17.82. It is -35.22% below current price. The 52-week High is 27.51. The stock hits 52-week high today. The 52-week Low is 11.11. It is -59.61% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CTMX is 2.89 on 2018-01-12. Short % to float is 3.05%. There are some statistics of CTMX. It is has market cap $1.06 billion. The share outstanding is 38.41 million. The average volume is 365941. The revenue is 50.82M. The percent of top 15 Institution holding is 82.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTMX is -83.17%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTMX is -19.63%.


Tags:

Share this post